Whitehawk Therapeutics (WHWK) Capital Expenditures Growth (3y) (2019 - 2025)
Whitehawk Therapeutics (WHWK) Capital Expenditures Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,200.25 Bn | 66,199.96 Bn | - | - |
| 2 | Nanobiotix | 1,908.00 Bn | 1,907.94 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 471.75 Bn | 466.96 Bn | 1.35 Bn | -12.25% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 46.88% |
| 6 | Regeneron Pharmaceuticals | 69.87 Bn | 61.12 Bn | 3.31 Bn | 8.97% |
| 7 | Belite Bio | 62.43 Bn | 62.43 Bn | - | - |
| 8 | Argenx Se | 55.86 Bn | 50.68 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 16.27% |
| 10 | Whitehawk Therapeutics | 256.87 Mn | 45.62 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -39.35% |
| Jun 30, 2025 | 40.33% |
| Mar 31, 2025 | -90.90% |
| Dec 31, 2024 | 83.73% |
| Dec 31, 2023 | -28.90% |
| Sep 30, 2023 | -414.66% |
| Dec 31, 2022 | 7,168.49% |
| Sep 30, 2022 | -267.55% |
| Jun 30, 2022 | 26.38% |
| Mar 31, 2022 | -41.23% |
| Dec 31, 2021 | -287.92% |
| Dec 31, 2020 | -195.68% |
| Jun 30, 2019 | 247.38% |
| Mar 31, 2019 | 0.85% |